UNC Investigators Help Prove a Monoclonal Antibody Prevents, Treats COVID-19 in Nursing Homes
Eli Lilly today released results of a clinical trial that found bamlanivimab, a monoclonal antibody, significantly reduced the risk of contracting COVID-19 among residents and staff of long-term care facilities. The Phase 3 trial was conducted in partnership with the NIH”s National Institute of Allergy and Infectious Diseases and the COVID-19 Prevention Network (CoVPN). Myron … Read more